1 / 20

Prioritising HTA funding: The benefits and challenges of using value of information in anger

CENTRE FOR HEALTH ECONOMICS. Prioritising HTA funding: The benefits and challenges of using value of information in anger. K Claxton, L Ginnelly, MJ Sculpher, Z Philips. Centre for Health Economics, University of York, UK. Overview. Overview of methods

nwainwright
Download Presentation

Prioritising HTA funding: The benefits and challenges of using value of information in anger

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. CENTRE FOR HEALTH ECONOMICS Prioritising HTA funding: The benefits and challenges of using value of information in anger K Claxton, L Ginnelly, MJ Sculpher, Z Philips. Centre for Health Economics, University of York, UK

  2. Overview • Overview of methods • Screening for age-related macular degeneration • Considered by NCCHTA diagnostic and screening panel • Manual chest physiotherapy techniques for asthma and chronic obstructive pulmonary disease • Considered by NCCHTA therapeutic procedures panel • long-term antibiotic treatment for preventing recurrent urinary tract infections (UTI) in children • Considered by Prioritisation Strategy Group (PSG)

  3. An overview of methods Background • Other methods • Research as a means changing clinical practice • Statistical decision theory • Reduction in the costs of decision uncertainty • Value consistent with objective and constraints of service provision Methods • Constructions of decision analytic model • Probabilistic analysis to characterise decision uncertainty • Value of information analysis

  4. Identifying research priorities • EVPI • Maximum return to research (decision problem) • Comparing the EVPI to the costs of research • Comparing EVPI across technologies • Partial EVPI • Maximum return to research (endpoint) • Comparing partial EVPIs • Considering the costs of research

  5. Screening for age-related macular degeneration (AMD) Options • Weekly self screening with Amsler grid • No screen but self referral on decline in visual acuity • No PDT treatment and no screening Indications • 1st eye neovascular AMD • 20/40 and 20/80 visual acuity • Male and female (age 55-64) • Eligibility of PDT consistent with NICE guidance Time horizon of 10 years NHS Perspective

  6. Model structure for AMD screening

  7. Manual chest physiotherapy techniques for asthma Patient groups • Children treated in the community • Adults treated in the community • Children treated in hospital Options • Massage therapy • Chiropractic spinal manipulation (CSM) • Physical therapy • No manual therapy Time horizon of 30-days NHS perspective

  8. Manual Chest Physiotherapy Techniques for adults with Chronic Obstructive Pulmonary Disease (COPD) Patient groups • Adults with stable COPD Options • Autogenic drainage • Active breathing, • Heat lamp • Chest percussion with drainage • No manual therapy Time horizon of 30-days NHS perspective

  9. Structure of the asthma and COPD model

  10. long-term antibiotic treatment for preventing recurrent urinary tract infections (UTI) in children Patient groups • Infants of 1 year and children age 3 • Girls and boys • Recurrent UTI (no abnormalities) • Mild VUR (grade I and II) Options • Long-term low dose antibiotics (Cochrane review) (Trimethoprim, Nitrofurantoin, Cotrimoxazole) • Intermittent treatment of UTIs Time horizon • 3 years of long-term antibiotics and follow-up to end stage renal disease NHS perspective

  11. Model Structure for UTI

  12. The evidence Effectiveness • Existing reviews (variable quality) • Meta analysis, Multiple parameter synthesis • Probabilistic trial based model Natural history • Epidemiological studies • Pooled trial baselines • Registry studies • Clinical judgement Quality of life • Published studies • Survey Costs • Published studies • Published unit costs and dosage (BNF, PSSRU, CIPFA)

  13. Results: cost-effectiveness acceptability curve

  14. Results: population EVPI (girls age 3 with no VUR)

  15. Partial EVPI (girls age 3 with no VUR)

  16. Results: EVPI

  17. Conclusions Asthma • Children treated in the community • Massage therapy may be cost-effective • Further research is potentially cost-effective • Effect of massage therapy on FEV1 (no value in effect of CSM) • Manual physiotherapy for adults treated in the community • Manual therapy not cost effective • Further research not cost-effective • Children treated in hospital • Physical therapy may be cost-effective • Further research is potentially cost-effective • Effect of physical therapy on hospital length of stay and FEV1 COPD • Manual chest physiotherapy for stable COPD is not cost-effective. • Further research not cost-effective • Inpatient manual chest physiotherapy?

  18. Conclusions AMD • Screening may be cost-effective • Further research appears to be potentially cost-effective • Evidence about the quality of life with and without PDT UTI Prophylaxis • Long-term antibiotics are cost-effective for all patient groups • Which of the antibiotics should be used is uncertain • Primary research maybe required for selected patient groups • girls age 3 with no VUR • Trials should include head to head comparisons • Cotrimoxazole and trimethoprim or all three antibiotics • Longer follow-up would be worthwhile • trials with 6 month follow-up are unlikely to be worthwhile

  19. Feasibility and policy impact • Feasibility • Completed despite not meeting selection criteria • Analysis conducted and presented within NCCHTA time lines • Policy impact • Mixed responses from panel members • Potential (selective) role at PSG • Impact on commissioning decisions

  20. Methods and implementation • Methods • More complex and resource intensive than anticipated • Comprehensive searching for model parameters • Methods of evidence synthesis • Quality of evidence (bias and exchangeability) • Sensitivity analysis (evidence, model structure) • Implementation • Communicating complex material • Requires an iterative process • Identifying topics where VoI should be conducted

More Related